An Activatable Nanoscintillator Probe for Detecting Telomerase Activity and Screening Inhibitors In Vivo

IF 3 4区 医学 Q2 PHARMACOLOGY & PHARMACY
Baoliu Chen, Junduan Dai, Sijie Song, Xianzhe Tang, Yu-lin Guo, Ting Wu, Meng-Han Wu, Chaojie Hao, Xiaofeng Cheng, Xucong Lin, Yijie Bian, Zhaowei Chen, Huanghao Yang
{"title":"An Activatable Nanoscintillator Probe for Detecting Telomerase Activity and Screening Inhibitors In Vivo","authors":"Baoliu Chen, Junduan Dai, Sijie Song, Xianzhe Tang, Yu-lin Guo, Ting Wu, Meng-Han Wu, Chaojie Hao, Xiaofeng Cheng, Xucong Lin, Yijie Bian, Zhaowei Chen, Huanghao Yang","doi":"10.3390/targets1010004","DOIUrl":null,"url":null,"abstract":"Telomerase represents an essential molecular machinery for tumor occurrence and progression and a potential therapeutic target for cancer treatment. Sensitive and reliable analysis of telomerase activity is of significant importance for the diagnosis and treatment of cancer. In this study, we developed a telomerase-activated nanoscintillator probe for deep-tissue and background-free imaging of telomerase activity and screening telomerase inhibitors in tumor-bearing living mice models. The probe was constructed by modifying lanthanide-doped nanoscintillators with aptamer-containing DNA anchor strands which hybridized with quencher labelled–oligonucleotide strands and telomerase primers. The X-ray-induced fluorescence of the probe was quenched originally but turned on upon telomerase-catalyzed extension of the primer. Benefiting from exceptional tissue penetrating properties and negligible autofluorescence of X-ray excitation, this probe enabled direct detection of telomerase activity in vivo via fluorescence imaging. Furthermore, with the direct, readable fluorescent signals, the probe enabled the screening of telomerase inhibitors in living cells and whole-animal models in the native states of telomerase. This strategy would inspire the development of low autofluorescence and deep tissue bioimaging probes for disease diagnosis and drug development in high-level living settings.","PeriodicalId":10805,"journal":{"name":"Current drug targets","volume":"33 1","pages":""},"PeriodicalIF":3.0000,"publicationDate":"2023-06-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Current drug targets","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.3390/targets1010004","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
引用次数: 1

Abstract

Telomerase represents an essential molecular machinery for tumor occurrence and progression and a potential therapeutic target for cancer treatment. Sensitive and reliable analysis of telomerase activity is of significant importance for the diagnosis and treatment of cancer. In this study, we developed a telomerase-activated nanoscintillator probe for deep-tissue and background-free imaging of telomerase activity and screening telomerase inhibitors in tumor-bearing living mice models. The probe was constructed by modifying lanthanide-doped nanoscintillators with aptamer-containing DNA anchor strands which hybridized with quencher labelled–oligonucleotide strands and telomerase primers. The X-ray-induced fluorescence of the probe was quenched originally but turned on upon telomerase-catalyzed extension of the primer. Benefiting from exceptional tissue penetrating properties and negligible autofluorescence of X-ray excitation, this probe enabled direct detection of telomerase activity in vivo via fluorescence imaging. Furthermore, with the direct, readable fluorescent signals, the probe enabled the screening of telomerase inhibitors in living cells and whole-animal models in the native states of telomerase. This strategy would inspire the development of low autofluorescence and deep tissue bioimaging probes for disease diagnosis and drug development in high-level living settings.
用于检测端粒酶活性和筛选体内抑制剂的可活化纳米闪烁探针
端粒酶是肿瘤发生发展的重要分子机制,是肿瘤治疗的潜在靶点。端粒酶活性的灵敏、可靠分析对癌症的诊断和治疗具有重要意义。在这项研究中,我们开发了一种端粒酶激活的纳米闪烁探针,用于端粒酶活性的深层组织和无背景成像,并在荷瘤小鼠模型中筛选端粒酶抑制剂。该探针是用含有核酸适配体的DNA锚链修饰镧掺杂纳米闪烁体,并与淬灭剂标记的寡核苷酸链和端粒酶引物杂交而成。探针的x射线诱导荧光最初被淬灭,但在端粒酶催化的引物延伸时开启。得益于特殊的组织穿透特性和x射线激发的可忽略的自身荧光,该探针能够通过荧光成像直接检测体内端粒酶活性。此外,通过直接可读的荧光信号,探针能够在端粒酶天然状态的活细胞和全动物模型中筛选端粒酶抑制剂。这一策略将激发低自身荧光和深层组织生物成像探针的发展,用于高水平生活环境中的疾病诊断和药物开发。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Current drug targets
Current drug targets 医学-药学
CiteScore
6.20
自引率
0.00%
发文量
127
审稿时长
3-8 weeks
期刊介绍: Current Drug Targets aims to cover the latest and most outstanding developments on the medicinal chemistry and pharmacology of molecular drug targets e.g. disease specific proteins, receptors, enzymes, genes. Current Drug Targets publishes guest edited thematic issues written by leaders in the field covering a range of current topics of drug targets. The journal also accepts for publication mini- & full-length review articles and drug clinical trial studies. As the discovery, identification, characterization and validation of novel human drug targets for drug discovery continues to grow; this journal is essential reading for all pharmaceutical scientists involved in drug discovery and development.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信